Episode 10: Trends in Risk-Based
Monitoring and RBQM in Clinical Trials
Join three subject-matter experts to help us wrap Season 3 of ACRO’s Good Clinical Podcast as we discuss trends in RBQM in both ongoing and new start studies.
Since 2019, ACRO’s RBQM Working Group has administered a yearly survey focused on industry adoption of RBM and RBQM components. Tune in to hear these leading voices discuss the latest survey’s findings and what the clinical research industry needs to know about RBM and RBQM adoption.
RBQM Working Group members Lauren Garson (Senior Director, Clinical Strategy, Veeva), Cris McDavid (Sr. Director, Global Clinical Operations, Parexel), and Jennifer Stewart (Executive Director, Clinical Data Sciences, Premier Research) join this final episode of the podcast.
This episode is available to stream on Spotify, Apple Podcasts, and YouTube.
RBQM Summary Report is LIVE Now!
ACRO announced the release of its latest RBQM Summary Report, highlighting key findings from six years of trial-level data on industry adoption of risk-based quality management (RBQM) components. Informed by conversations with the FDA, the aim of the survey is to improve our understanding of how RBQM is being adopted across the clinical trial industry.